Potential anticancer heterometallic Fe-Au and Fe-Pd agents: Initial mechanistic insights

Journal of Medicinal Chemistry

Volumn 56, Issue 14, 2013, Pages 5806-5818

  Lease, Nicholas ^a   Vasilevski, Vadim ^a   Carreira, Monica ^a   De Almeida, Andreia ^b   Sanaú, Mercedes ^c   Hirva, Pipsa ^d   Casini, Angela ^b   Contel, María ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF VALENCIA   (Spain)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FERROCENYLPHOSPHANE DERIVATIVE; GOLD; IMINOPHOSPHORANE LIGAND; IRON; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PALLADIUM; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROPHORESIS; HUMAN; HUMAN CELL; IC 50; KIDNEY CELL; OVARY CANCER; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CISPLATIN; COORDINATION COMPLEXES; FERROUS COMPOUNDS; HEK293 CELLS; HUMANS; ORGANOGOLD COMPOUNDS; ORGANOMETALLIC COMPOUNDS; PALLADIUM;

EID: 84880893214     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm4007615     Document Type: Article

References (80)

1. Thayer, A. M. Platinum drugs take their roll Chem. Eng. News 2010, 88 (26) 24-28
2. Kelland, L. The resurgence of platinum-based cancer chemotherapy Nat. Rev. Cancer 2007, 7, 573-584
3. Alessio, E. Bioinorganic Medicinal Chemistry; Wiley-VCH: Weinheim, Germany, 2011.
4. Noffke, A. L.; Habtemarian, A.; Pizarro, A. M.; Sadler, P. J. Designing organometallic compounds for catalysis and therapy Chem. Commun. 2012, 48, 5219-5246
5. Aris, S. M.; Farrell, N. P. Towards antitumor active trans -platinum compounds Eur. J. Inorg. Chem. 2009, 1293-1302
6. Berners-Price, S. J.; Filipovska, A. Gold compounds as therapeutic agents for human diseases Metallomics 2011, No. 41, 279-304
7. Komeda, S.; Casini, A. Next-generation anticancer metallodrugs Curr. Top. Med. Chem. 2012, 12, 219-223
8. Bergamo, A.; Gaiddon, C.; Schellens, J. H. M.; Beijnen, J. H.; Sava, G. Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates J. Inorg. Biochem. 2012, 106, 90-99
9. Casini, A. Exploring the mechanisms of metal-based pharmacological agents via an integrated approach J. Inorg. Biochem. 2012, 109, 97-106
10. Nobili, S.; Mini, E.; Landini, I.; Gabbiani, C.; Casini, A.; Messori, L. Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies Med. Res. Rev. 2010, 30, 550-580
11. Casini, A.; Hartinger, C.; Gabbiani, C.; Mini, E.; Dyson, P. J.; Keppler, B. K.; Messori, L. Gold(III) compounds as anticancer agents: relevance of gold-protein interactions for their mechanism of action J. Inorg. Biochem. 2008, 102, 564-575
12. Bergamo, A.; Sava, G. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs Dalton Trans. 2011, 40, 7817-7823
13. Pizarro, A. M.; Habtemarian, A.; Sadler, P. Activation mechanisms for organometallic anticancer complexes Top. Organomet. Chem. 2010, 32, 21-56
14. Casini, A.; Reedijk, J. Interactions of anticancer Pt compounds with proteins: an overlooked topic in medicinal inorganic chemistry? Chem. Sci. 2012, 3, 3135
15. Schuh, E.; Pfluger, C.; Citta, A.; Folda, A.; Rigobello, M. P.; Bindoli, A.; Casini, A.; Mohr, F. Gold(I) carbene complexes causing thioredoxin 1 and thioredoxin 2 oxidation as potential anticancer agents J. Med. Chem. 2012, 55, 5518-5528 and references therein
16. Berners-Price, S. J.; Filipovska, A. Gold compounds as therapeutic agents for human diseases Metallomics 2011, 3, 863-873
17. Dalla Via, L.; Nardon, C.; Fregona, D. Targeting the ubiquitin-proteasome pathway with inorganic compounds to fight cancer: a challenge for the future Future Med. Chem. 2012, 4, 525-543
18. Serratrice, M.; Edafe, F.; Mendes, F.; Scopelliti, R.; Zakeeruddin, S. M.; Gratzel, M.; Santos, I.; Cinellu, M. A.; Casini, A. Cytotoxic gold compounds: synthesis, biological characterization and investigation on their inhibition properties of the zinc finger protein PARP-1 Dalton Trans. 2012, 41, 3287-3293
19. Mendes, F.; Groessl, M.; Nazarov, A. A.; Tsybin, Y. O.; Sava, G.; Santos, I.; Dyson, P. J.; Casini, A. Metal-based inhibition of poly(ADP-ribose) polymerase-the guardian angel of DNA J. Med. Chem. 2011, 54, 2196-2206
20. Schreiber, V.; Dantzer, F.; Ame, J. C.; de Murcia, G. Poly(ADP-ribose): novel functions for an old molecule Nat. Rev. Mol. Cell. Biol. 2006, 7, 517-528
21. Jeggo, P. A. DNA-repair: PARP-another guardian angel? Curr. Biol. 1997, 8, R49-R51
22. Donzello, M. P.; Viola, E.; Ercolani, C.; Fu, Z.; Futur, D.; Kadish, K. M. Tetra-2,3-pyrazinoporphyrazines with externally appended pyridine rings. 12. New heteropentanuclear complexes carrying four exocyclic cis-platin-like functionalities as potential bimodal (PDT/cis-platin) anticancer agents Inorg. Chem. 2012, 51, 12548-12559 and references therein
23. 2 and TiM (M = Pd, Pt) compounds. Studies of their interactions with DNA Inorg. Chem. 2011, 50, 11099-11110
24. Wenzel, M.; Bertrand, B.; Eymin, M.-J.; Comte, V.; Harvey, J. A.; Richard, P.; Groessl, M.; Zava, O.; Amrouche, H.; Harvey, P. D.; Le Gendre, P.; Picquet, M.; Casini, A. Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes Inorg. Chem. 2011, 50, 9472-9480
25. Pelletier, F.; Comte, V.; Massard, A.; Wenzel, M.; Toulot, S.; Richard, P.; Picquet, M.; Le Gendre, P.; Zava, O.; Edafe, F.; Casini, A.; Dyson, P. J. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties J. Med. Chem. 2010, 53, 6923-6933
26. CG, Phillips, A. D.; Nazarov, A. A. Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics Curr. Top. Med. Chem. 2011, 11, 2688-2702
27. Hillard, E. A.; Vessieres, A.; Jaouen, G. Ferrocene functionalized endocrine modulators as anticancer agents Top. Organomet. Chem. 2010, 32, 81-117
28. Snegur, L. V.; Babin, V. N.; Simenel, A. A.; Nekrasov, Y. S.; Ostrovskaya, L. A.; Sergeeva, N. S. Antitumor activities of ferrocene compounds Russ. Chem. Bull., Int. Ed. 2010, 59, 2167-2178
29. Recent relevant example: Plazuk, D.; Wieczorek, A.; Blauz, A.; Rychlik, B. Synthesis and biological activities of ferrocenyl derivatives of paclitaxel Med. Chem. Commun. 2012, 3, 498-501
30. Bjelosevic, H.; Guzei, I. A.; Spencer, L. C.; Persson, T.; Kriel, F. H.; Hewer, R.; Nell, M. J.; Gut, J.; van Rensburg, C. E. J.; Rosenthal, P. J.; Coates, J.; Darkwa, J.; Elmroth, S. K. C. Platinum(II) and gold(I) complexes based on 1,1-bis(diphenylphosphino)metallocene derivatives: synthesis, characterization and biological activity of the gold complexes J. Organomet. Chem. 2012, 720, 52-59
31. Gimeno, M. C.; Goitia, H.; Laguna, A.; Luque, M. E.; Villacampa, M. D.; Sepulveda, C.; Meireles, M. Conjugates of ferrocene with biological compounds. Coordination to gold complexes and antitumoral properties J. Inorg. Biochem. 2011, 105, 1373-1382
32. Fourie, E.; Erasmus, E.; Swarts, J. C.; Jakob, A.; Lang, H.; Joone, G. K.; van Rensburg, C. E. J. Cytotoxicity of ferrocenyl-ethynyl phosphine metal complexes of gold and platinum Anticancer Res. 2011, 31, 825-830
33. Horvath, U. E. I.; Bentivoglio, G.; Hummel, M.; Schottenbergm, H.; Wurst, K.; Nell, M. J.; van Rensburg, C. E. J.; Cronje, S.; Raubenhemier, H. C. A cytotoxic bis(carbene)gold(I) complex of ferrocenyl complexes: synthesis and structural characterization New. J. Chem. 2008, 32, 533-539
34. Viotte, M.; Gautheron, B.; Ninfant'ev, I.; Kuz'mina, L. G. New potentially cytotoxic thiolatogold(I) complexes of 1,1′- bis(diphenylphopshino)ferrocene Inorg. Chim. Acta 1996, 253, 71-76
35. Viotte, M.; Gautheron, B.; Kubicki, M. M.; Ninfant'ev, I.; Fricker, S. P. Synthesis, structure of nitrogen-containig phosphinogold(I) ferrocenes. In vitro activity against bladder and colon carcinoma cell lines Met.-Based Drugs 1995, 2, 311-326
36. Viotte, M.; Gautheron, B.; Kubicki, M. M.; Mugnier, Y.; Parish, R. V. New iron(II)- and gold(I)-containing metallocenes. X-ray structure of a three-coordinate gold(I) ferrocenophane-type representative Inorg. Chem. 1995, 34, 3465-3473
37. Nieto, D.; Gonzalez-Vadillo, A. M.; Bruna, S.; Pastor, C. J.; Rios-Luci, C.; Leon, L. C.; Padron, J. M.; Navarro-Ranninger, C.; Cuadrado, I. Heterodimetallic platinum(II) compounds with β-aminoethylferrocenes: synthesis, electrochemical behavior and anticancer activity Dalton. Trans. 2012, 41, 432-441
38. Chellan, P.; Land, K. M.; Shokar, A.; Au, A.; An, S. H.; Clavel, C. M.; Dyson, P. J.; de Kock, C.; Smith, P. J.; Chibale, K.; Smith, G. S. Exploring the versatility of cycloplatinated thiosemicarbazones as antitumor and antiparasitic agents Organometallics 2012, 31, 5791-5799
39. Samouei, H.; Rashidi, M.; Heinemann, F. W. A cyclometalated diplatinum complex containing 1,1′-bis(diphenylphoshino)ferrocene as spacer ligand: antitumor study J. Organomet. Chem. 2011, 696, 3764-3771
40. Schulz, J.; Renfrew, A. K.; Cisarova, I.; Dyson, P. J.; Stepnicka, P. Synthesis and anticancer activity of chalcogenide derivatives and platinum(II) and palladium(II) complexes derived from a polar ferrocene-phosphanyl- carboxamide Appl. Organomet. Chem. 2010, 24, 392-397
41. Rajput, J.; Moss, J. R.; Hutton, A. T.; Hendricks, D. T.; Arendse, C. E.; Imrie, C. Synthesis, characterization and cytotoxicity of some palladium(II), platinum(II), rhodium(I) and iridium(I) complexes of ferrocenylpyridine and relataed ligands. Crystal and molecular structure of trans-dichlorobis(3- ferrocenylpyridine)palladium(II) J. Organomet. Chem. 2004, 689, 1553-1568
42. Henderson, W.; Alley, S. R. Platinum(II) complexes containing ferrocene-derived phosphonate ligands; synthesis, structural characterization and antitumor activity Inorg. Chim. Acta 2001, 322, 106-112
43. Mason, R. W.; McGrouter, K.; Ranatunge-Bandarage, P. R. R.; Robinson, B. H.; Simpson, J. Toxicology and antitumour activity of ferrocenylamines and platinum derivatives Appl. Organomet. Chem. 2001, 13, 163-173
44. Bincoletto, C.; Tersariol, I. L. S.; Oliveira, C. R.; Dreher, S.; Fausto, D. M.; Soufen, A. S.; Nascimento, F. D.; Caires, A. C. F. Chiral cyclopalladated complexes derived from N, N -dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumor agents Bioorg. Med. Lett. 2005, 13, 3047-3055
45. Barbosa, C. M. V.; Oliveira, C. R.; Nascimiento, F. D.; Smith, M. C. M.; Fausto, D. M.; Soufen, M. A.; Sena, E.; Araujo, R. C.; Tersariol, I. L. S.; Bincoletto, C.; Caires, A. C. F. Biphosphinic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells Eur. J. Pharmacol. 2006, 542, 37-47
46. Oliveira, C. R.; Barbosa, C. M. V.; Nascimento, F. D.; Lanetzki, C. S.; Meneghin, M. B.; Pereira, F. E. V.; Paredes-Gamero, E. J.; Ferreira, A. T.; Rodrigues, T.; Queiroz, M. L. S.; Caires, A. C. F.; Tersariol, I. L. S.; Bincoletto, C. Pre-clinical antitumour evaluation of biphosphinic palladacycle complex in human leukaemia cells Chem.-Biol. Interact. 2009, 177, 181-189
47. Tauchman, J.; Suss-Fink, G.; Stepnicka, P.; Zava, O.; Dyson, P. J. Arene ruthenium complexes with phosphinoferrocene amino acid conjugates: synthesis, characterization and cytotoxicity J. Organomet. Chem. 2013, 723, 233-238
48. Ott, I.; Kowalski, K.; Gust, K.; Maurer, J.; Mucke, P.; Winter, R. F. Comparative biological evaluation of two ethylene linked mixed binuclear ferrocene/ruthenium organometallic species Bioorg. Med. Chem. Lett. 2010, 20, 866-869
49. 2] J. Organomet. Chem. 2009, 694, 855-861
50. Wu, C.-H.; Wu, D.-H.; Liu, X.; Guoyiqibayi, G.; Guo, D.-D.; Lv, G.; Wang, X.-M.; Yan, H.; Jiang, H.; Lu, Z.-H. Ligand-based neutral ruthenium(II) arene complex: selective anticancer action Inorg. Chem. 2009, 48, 2352-2354
51. 3(NO)(dppf)], dppf = 1,1′-bis(diphenylphosphine)ferrocene Polyhedron 2007, 26, 4707-4712
52. Conradie, J.; Swarts, J. C. Relationship between electrochemical potentials and substitution reaction rates of ferrocene-containing B-diketonato rhodium(I) complexes; cytotoxicity of [Rh(FcCOCHCOPh)(cod)] Dalton Trans. 2011, 40, 5844-5851
53. Weber, B.; Serafin, A.; Michie, J.; van Rensburg, C.; Swarts, J. C.; Bohm, L. Cytotoxicity and cell death pathways invoked by two new rhodium-ferrocene complexes in benign and malignant prostatic cell lines Anticancer Res. 2004, 24, 763-770
54. Sathyadevi, P.; Krishnamoorthy, P.; Burotac, R. R.; Cowley, A. H.; Dharmaraj, N. Synthesis of novel heterometallic copper(I) hydrazone Schiff base complexes: a comparative study on the effect of heterocyclic hydrazides towards interaction with DNA/protein, free radical scavenging and cytotoxicity Metallomics 2012, 4, 498-511
55. Maity, B.; Roy, M.; Banik, B.; Majumdar, R.; Dighe, R. R.; Chakravarty, A. R. Ferrocene-promoted photoactivated DNA cleavage and anticancer activity of terpyridyl copper(II) phenantroline complexes Organometallics 2010, 29, 3632-3641
56. Shaik, N.; Martínez, A.; Augustin, I.; Giovinazzo, H.; Varela, A.; Aguilera, R.; Sanaú, M.; Contel, M. Synthesis of apoptosis-inducing iminophosphorane organogold(III) complexes and study of their interactions with biomolecular targets Inorg. Chem. 2009, 48, 1577-1587
57. Vela, L.; Contel, M.; Palomera, L.; Azaceta, G.; Marzo, I. Iminophosphorane-organogold(III) complexes induce cell death through mitochondrial ROS production J. Inorg. Biochem. 2011, 105, 1306-1313
58. 8 metals. Studies of their interactions with DNA and HSA J. Inorg. Biochem. 2012, 116, 204-214
59. Carreira, M.; Calvo-Sanjuán, R.; Sanaú, M.; Marzo, I.; Contel, M. Organometallic palladium complexes with a water-soluble iminophosphorane ligand as potential anticancer agents Organometallics 2012, 31, 5772-5781
60. Staudinger, H.; Meyer, J. J. Über neue organische phosphorverbindungen III. Phosphinmethylenderivate und phosphinimine Helv. Chim. Acta 1919, 2, 635-646
61. Sollott, G. P.; Mertwoy, H. E.; Portnoy, S.; Snead, J. L. Unsymmetrical tertiary phosphines of ferrocene by Friedel-Crafts reactions. I. Ferrocenylphenylphosphines J. Org. Chem. 1963, 28, 1090-1092
62. Aguilar, D.; Contel, M.; Navarro, R.; Soler, T.; Urriolabeitia, E. P. Gold(III) iminophosphorane complexes as catalysts in C-C and C-O bond formations J. Organomet. Chem. 2009, 694, 486-493
63. Vicente, J.; Abad, J. A.; Clemente, R.; Lopez-Serrano, J.; Ramirez de Arellano, M. C.; Jones, P. G.; Butista, D. Mercurated and palladated Iminophosphoranes. Synthesis and reactivity Organometallics 2003, 22, 4248-4259
64. II complexes (M=Pd, Pt) New J. Chem. 1999, 35, 227-235
65. 2, to platinum(II) Inorg. Chem. 1996, 35, 1518-1528
66. Baker, J.; Jarzecki, A. A.; Pulay, P. Direct scaling of primitive valence force constants: an alternative approach to scaled quantum mechanical force fields J. Phys. Chem. A 1998, 1412-1424
67. Dabrowiak, J. C. Metals in Medicine; John Wiley and Sons, Ltd.: Chichester, U.K., 2009; Chapter 4, pp 109-114.
68. Liu, H.-K.; Sadler, P. Metal complexes as DNA intercalators Acc. Chem. Res. 2011, 44, 349-359
69. For example: Ruíz, J.; Cutillas, N.; Vicente, C.; Villa, M. D.; López, G.; Lorenzo, J.; Avilés, F. X.; Moreno, V.; Bautista, D. New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA Inorg. Chem. 2005, 44, 7365-7376
70. Gao, E.; Zhu, M.; Liu, L.; Huang, Y.; Wang, L.; Shi, S.; Chuyue, Z. W.; Sun, Y. Impact of the carbon chain length of novel palladium(II) complexes on interaction with DNA and cytotoxic activity Inorg. Chem. 2010, 49, 3261-3270
71. Quiroga, A.; Pérez, J. M.; López-Solera, I.; Masaguer, J. R.; Luque, A.; Román, P.; Edwards, A.; Alonso, C.; Navarro-Ranninguer, C. Novel tetranuclear orthometalated complexes of Pd(II) and Pt(II) derived from p -isopropylbenzaldehyde thiosemicarbazone with cytotoxic activity in cis-DDP resistant tumor cell lines. Interaction of these complexes with DNA J. Med. Chem. 1998, 41, 1399-1408
72. Gao, E.-J.; Wang, K.-H.; Zhu, M.-C.; Liu, L. Hairpin-shaped tetranuclear palladium(II) complex: synthesis, crystal structure, DNA binding and cytotoxicity activity studies Eur. J. Med. Chem. 2010, 45, 2784-2790
73. Drug-DNA Interaction Protocols; Fox, K., Ed.; Methods in Molecular Biology, Vol. 90; Humana Press Inc: Totowa, NJ, 1997.
74. Gumus, F.; Eren, G.; Acik, L.; Celebi, A.; Ozturk, F.; Yilmaz, S.; Sagkan, R. I.; Gur, S.; Ozkul, A.; Elmali, A.; Elerman, Y. Synthesis, cytotoxicity, and DNA interactions of new cisplatin analogues containing substituted benzimidazole ligands J. Med. Chem. 2009, 52, 1345-1357
75. Timerbaev, A. R.; Hartinger, C. G.; Aleksenko, S. S.; Keppler, B. K. Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology Chem. Rev. 2006, 106, 2224-2248
76. Lacowicz, J. R. Principles of Fluorescence Spectroscopy; Kluwer Academic/Plenum Publishers: New York, 1999; Chapter 8, pp 238-264.
77. M1: Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, revision C.01; Gaussian, Inc.: Wallingford, CT, 2009.
78. Perdew, J. P.; K. Burke, K.; Ernzerhof, M. Generalized gradient approximation made simple Phys. Rev. Lett. 1996, 77, 3865-3868
79. Andrae, D.; Häußermann, U.; Dolg, M.; Stoll, H.; Preuß, P. Energy-adjusted ab initio pseudopotentials for the second and third row transition elements Theor. Chim. Acta 1990, 77, 123-141
80. Cossi, M.; Rega, N.; Scalmani, G.; Barone, V. Energies, structures, and electronic properties of molecules in solution with the C-PCM solvation model J. Comput. Chem. 2003, 24, 669-681